Seeing Is Believing
RYTM is currently covered by 9 analysts with an average price target of $66.07. This is a potential upside of $10.48 (18.85%) from yesterday's end of day stock price of $55.59.
Rhythm Pharmaceuticals's activity chart (see below) currently has 55 price targets and 86 ratings on display. The stock rating distribution of RYTM is 86.36% BUY and 13.64% HOLD.
Analysts average stock forecasts to be materialized ratio is 84.81% with an average time for these price targets to be met of 418.42 days.
Highest price target for RYTM is $80, Lowest price target is $52, average price target is $66.07.
Most recent stock forecast was given by CORINNE JENKINS from GOLDMAN SACHS on 05-Dec-2024. First documented stock forecast 30-Oct-2017.
Currently out of the existing stock ratings of RYTM, 38 are a BUY (86.36%), 6 are a HOLD (13.64%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$66
$10.41 (18.73%)
$52
24 days ago
(05-Dec-2024)
8/9 (88.89%)
$6.65 (11.20%)
187
Buy
$64
$8.41 (15.13%)
$55
1 months 23 days ago
(06-Nov-2024)
15/15 (100%)
$0.64 (1.01%)
128
Buy
$80
$24.41 (43.91%)
$79
1 months 23 days ago
(06-Nov-2024)
2/5 (40%)
$16.64 (26.26%)
502
Buy
$65
$9.41 (16.93%)
$50
1 months 23 days ago
(06-Nov-2024)
3/3 (100%)
$1.64 (2.59%)
758
Hold
$52
$-3.59 (-6.46%)
$42
2 months 15 days ago
(14-Oct-2024)
11/11 (100%)
$1.76 (3.50%)
176
What is RYTM (Rhythm Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on RYTM (Rhythm Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on RYTM (Rhythm Pharmaceuticals)?
Which analyst is the currently most bullish on RYTM (Rhythm Pharmaceuticals)?
Which analyst is the currently most reserved on RYTM (Rhythm Pharmaceuticals)?